Evidence map›Paper›PMID 23580110›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2013

Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.

Ana M Sánchez-Torres, Virginia Basterra, Araceli Rosa, Lourdes Fañanás, Amalia Zarzuela, Berta Ibáñez, Víctor Peralta, Manuel J Cuesta

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Therapeutic targets in major psychiatric disorders revisited.European archives of psychiatry and clinical neuroscience · 2013
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana M Sánchez-TorresPsychiatric Unit B, Complejo Hospitalario de Navarra, c/Irunlarrea, 4, 31008, Pamplona, Spain.
Virginia Basterra
Araceli Rosa
Lourdes Fañanás
Amalia Zarzuela
Berta Ibáñez
Víctor Peralta
Manuel J Cuesta

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between cannabis and cognitive performance is controversial. While both acute administration and long-term cannabis use impair cognitive performance in healthy subjects, several studies have shown improved cognitive outcomes in patients with schizophrenia spectrum disorders who use cannabis. The aim of this study was to determine the relationship between lifetime cannabis use, as assessed longitudinally over 10 years of follow-up in a sample of 42 patients and 35 of their unaffected siblings, and current cognitive performance. Forty-two healthy control subjects were assessed at follow-up with the same instruments. Stepwise linear regression revealed a negative effect of longitudinal cannabis use on performance in a social cognition task in the patient group. In the sibling group, lifetime cannabis use had a negative effect on processing speed and declarative memory performance. In the control group, cannabis use per se did not predict cognitive performance; however, when adding lifetime tobacco use to the model, we found a negative association between lifetime cannabis and tobacco use and processing speed and social cognition performance. Moreover, a lower IQ associated with current cannabis use predicted worse attentional performance in the control group. The differential pattern of associations between cannabis use and cognitive performance in patients compared with siblings and controls can be explained by the negative impact of illness on cognition.

Indexed as

Schizophrenic PsychologyAdolescentAdultAttentionCognition DisordersExecutive FunctionFemaleHumansIntelligenceLinear ModelsLongitudinal StudiesMaleMarijuana AbuseMemory, EpisodicNeuropsychological TestsPsychiatric Status Rating Scales

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.